Overview

A Study of Total Neoadjuvant Therapy for High-risk Locally Advanced Rectal Cancer

Status:
Recruiting
Trial end date:
2023-06-01
Target enrollment:
Participant gender:
Summary
A Phase II Study of Total Neoadjuvant Therapy for High-risk Locally Advanced Rectal Cancer
Phase:
Phase 2
Details
Lead Sponsor:
Chinese Academy of Medical Sciences
Collaborators:
Beijing Cancer Hospital
Cancer Hospital of Guizhou Province
Jilin Provincial Tumor Hospital
Peking Union Medical College Hospital
Xijing Hospital